Log In
BCIQ
Print this Print this
 

SKI-O-282

  Manage Alerts
Collapse Summary General Information
Company Genosco
DescriptionOral spleen tyrosine kinase (SYK) inhibitor
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionSyk kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today